Loading...
Back
PRQR
PRQR
PROQR THERAPEUTICS NV
(PRQR)
2024 6-K
Follow
Summary
Share
Summary
Investor Event Announcement
25 Mar '26
2025 Results Announced
12 Mar '26
Board Changes Announced
9 Feb '26
ProQR Updates
8 Jan '26
Quarterly Results
6 Nov '25
Analyst Event Summary
3 Nov '25
Regulatory Update
20 Oct '25
Q2 Financial Results
7 Aug '25
Clinical Trial Announcement
26 Jun '25
Annual Meeting Results
3 Jun '25
First Quarter Results
8 May '25
Shareholder Meeting Announc...
1 May '25
Leadership Appointments
14 Apr '25
Annual Financial Results
13 Mar '25
Filing Amendment
12 Dec '24
Investor Event Update
11 Dec '24
Funding Announcement
11 Dec '24
Management Change
10 Dec '24
Investor Event Announcement
5 Dec '24
Q3 2024 Results
7 Nov '24
Equity Offering
25 Oct '24
Quarterly Results
8 Aug '24
Annual Meeting Results
22 May '24
Financial Results Report
9 May '24
New Program Data
8 May '24
Board Nomination Notice
23 Apr '24
Axiomer IP Defense
19 Apr '24
Year End Results
13 Mar '24
Patent Upheld
15 Feb '24
New Data Release
19 Jan '24
New Collaboration
5 Jan '24
External Links:
SEC
On March 13, 2024, ProQR Therapeutics N.V. reported its financial results for the year ending December 31, 2023, including a detailed business update.
AI Assistant
Close
PROQR THERAPEUTICS NV
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.